References
Aderounmu AF, Salako LA, Lindstrom B, Walker O, Ekman L (1986) Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Brit J Clin Pharmacol 22: 559–564
Ahmad RA, Rogers HJ (1980) Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. Br J Clin Pharmacol 10: 519–524
Anonymous (1983) Pyrimethamine combinations in pregnancy. Lancet 2: 1005–1006
Bateman DN, Dyson EH (1986) Quinine toxicity. Adv Drug React Ac Pois Rev 4: 215–233
Bergqvist Y, Domeij-Nyberg B (1983) Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr 272: 137–148
Boots M, Phillips M, Curtis JR (1982) Megaloblastic anaemia and pancytopenia due to proguanil in patients with chronic renal failure. Clin Nephrol 18: 106–108
Brodie BB, Baer JE, Craig LC (1951) Metabolic products of the cinchona alkaloids in human urine. J Biol Chem 188: 567–581
Carson PE, Hohl R, Nora MV, et al. (1981) Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man. Bull WHO 59: 427–437
Chanthavanich P, Looareesuwan S, White NJ, Warrell DA, Warrell MJ, Di Giovanni JH, Von Bredow J (1985) Intragastric mefloquine is absorbed rapidly in patients with cerebral malaria. Am J Trop Med Hyg 34: 1028–1036
Chongsuphajaisiddhi T, Daurag V, Patchavakessakul V, Kittivattanaku V, Dulyasakdi B, Ridthimat W (1983) Treatment of falciparum malaria with intramuscular quinine in rural area of Thailand. SE Asian J Trop Med Publ Health 14: 220–222
Churchill FC, Mount DL, Patchen LC (1986) Isolation characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods. J Chromatogr 377: 307–318
Cook IF, Kish MY (1985) Haematological safety of long-term malarial prophylaxis with dapsone pyrimethamine. Med J Aust 143: 139–141
Clyde DF (1981) Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull WHO 59: 391–395
Cosgriff TM, Boudreau EF, Pamplin CL, Doberstyn EB, Desjardins RE, Canfield CJ (1982) Evaluation of the antimalarial activity of the phenanthrene methanol halofantrine (WR 171669). Am J Trop Med Hyg 31: 1075–1079
Desjardins RE, Pamplin CL, Von Bredow J, Barry KG, Canfield CJ (1979) Kinetics of a new antimalarial, mefloquine. Clin Pharmacol Ther 26: 372–379
Fletcher KA, Price Evans DA, Gilles HM, Greaves J, Bunnag D, Harinasuta T (1981) Studies on the pharmacokinetics of primaquine. Bull WHO 59: 407–412
Frisk-Holmberg M, Bergqvist Y, Domeij-Nyberg B, Hellström L, Jansson F (1979) Chloroquine serum concentrations and side-effects: Evidence for dose dependent kinetics. Clin Pharmacol Ther 25: 345–350
Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B (1984) The single dose kinetics of chloroquine and its major metabolite desethyl-chloroquine in healthy subjects. Eur J Clin Pharmacol 26: 521–530
Fu S, Bjorkman A, Wahlin B, Ofori-Adjei D, Ericsson O, Sjöqvist F (1986) In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine againstPlasmodium falciparum. Br J Clin Pharmacol 22: 93–96
Gramiccia G (1987) Notes on the early history of cinchona plantations. Acta Leidensia 55: 5–13
Gustafsson LL, Rombo L, Alvan G, Bjorkman A, Lin M, Walker O (1983a) On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther 34: 383–385
Gustafsson LL, Walker O, Alvan G, Beerman B, Estevez F, Gleisner L, Lindström B, Sjöqvist F (1983b) Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15: 471–479
Gustafsson LL, Lindström B, Grahnen A, Alvan E (1987) Chloroquine excretion following malaria prophylaxis. Br J Clin Pharmacol 24: 221–224
Hall AP, Czerwinski AW, Madonia EC, Evensen KL (1973) Human plasma and urine quinine levels following tablets, capsules and intravenous infusion. Clin Pharmacol Ther 14: 580–585
Harinasuta T, Bunnag D, Wernsdorfer W (1983) A phase II clinical trial of mefloquine in patients with chloroquine resistant falciparum malaria in Thailand. Bull WHO 61: 299–305
Hatton C, Peto T, Bunch C, Pasvol G, Russell SJ, Singer CRJ, Edwards G, Winstanley P (1986) Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1: 411–414
Hellgren U, Rombo L, Berg B, Carlson J, Wiholm BE (1987) Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers. Implications for prophylaxis. Br Med J 295: 365–366
Karbwang J, Bunnag D, Breckenridge AM, Back DJ (1987) The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects. Eur J Clin Pharmacol 32: 173–177
Larrey D, Castot A, Pessayre D, Merigot P, Machayekhy JP, Feldmann G, Lenoir A, Rueff B, Benhamov JP et al. (1986) Amodiaquine-induced hepatitis. A report of seven cases. Ann Intern Med 104: 801–803
Laveran A (1880) Nôte sur un nouveau parasite dans le sang de plusieurs malades atteints de fièvre palustre. Nôte communiquée à l'Academie de Medicine, séance du 23 Nov Paris
Li G, Guo X, Jin R (1982) Clinical studies on treatment of cerebral malaria with Qinghaosu and its derivatives. J Trad Chinese Med 2: 125–130
Li G, Arnold K, Guo X, Jian H, Fu L (1984) Randomised comparative study of mefloquine, qinghaosu and pyrimethamine-sulfadoxine in patients with falciparum malaria. Lancet 2: 1360–1361
Looareesuwan S, Phillips RE, White NJ, Kietinun S, Karbwang J, Rackow C, Turner RC, Warrell DA (1985) Quinine and severe falciparum malaria in late pregnancy. Lancet 2: 4–8
Looareesuwan S, Phillips RE, White NJ, Karbwang J, Benjasurat Y, Attanath P, Warrell DA (1985) Intravenous amodiaquine and oral amodiaquine-erythromycin in the treatment of chloroquine resistant falciparum malaria. Lancet 2: 805–808
Looareesuwan S, White NJ, Chanthavanich P, Edwards G, Nicholl DD, Bunch C, Warrell DA (1986) Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. Br J Clin Pharmacol 22: 31–36
Looareesuwan S, White NJ, Warrell DA, Fargo I, Dubach UC, Ranalder UB, Schwartz DE (1987) Studies of mefloquine bioavailability and kinetics using a stable isotope technique: A comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol 24: 37–42
Mihaly GW, Ward SA, Edwards G, L'Eorme M, Breckenridge AM (1984) Pharmacokinetics of primaquine in man: Identification of the carboxylic acid derivative as a major plasma metabolite. Br J Clin Pharmacol 17: 441–446
Mihaly GW, Ward SA, Edwards G, Nicholl DD, L'Eorme M, Breckenridge AM (1985) Pharmacokinetics of primaquine in man I. Studies of the absolute bioavailability and effects of dose size. Br J Clin Pharmacol 19: 745–750
Miller KD, Lobel HD, Satriale RF, Kuritsky JN, Stern R, Campbell CC (1986) American travellers using Pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg 35: 451–458
Okitolonda W, Dellacollette C, Mallengrean M, Henquin JC (1987) High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. Br Med J 295: 716–718
Phillips RE, Warrell DA, White NJ, Looareesuwan S, Karbwang J (1985) Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and Pharmacokinetic studies. N Engl J Med 312: 1273–1278
Phillips RE, Looareesuwan S, White NJ, Silamut K, Kietinun S, Warrell DA (1986) Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria. Br J Clin Pharmacol 21: 677–683
Phillips RE, Looareesuwan S, White NJ, Chanthavanich P, Karbwang J, Supanaranond W, Turner RC, Warrell DA (1986) Hypoglycaemia and antimalarial drugs: quinidine and release of insulin. Br Med J 292: 1319–1321
Powell RD, McNamara JV (1972) Quinine: Side-effects and plasma levels. Proc Helminth Soc Wash 39: 331–338
Sabcharoen A, Chongsuphajaisiddhi T, Attanath P (1982) Serum quinine concentrations following the initial dose in children with falciparum malaria. SE Asian J Trop Med Publ Health 13: 556–562
Salako LA, Walker O, Iyun AO (1984a) Pharmacokinetics of chloroquine in renal failure. Afr J Med Med Sci 13: 177–182
Salako LA (1984b) Toxicity and side-effects of antimalarials in Africa. A critical review. Bull WHO 62 [Suppl]: 63–68
Schwartz DE, Eckert G, Hartmann D, Weber B, Richard-Lenoble D, Ekue JMK, Gentilini M (1982) Single dose kinetics of mefloquine in man. Chemotherapy 28: 70–84
Shann F, Stace J, Edstein M (1985) Pharmacokinetics of quinine in children. J Pediatr 106: 506–510
Silamut K, White NJ, Looareesuwan S, Warrell DA (1985) Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg 34: 681–686
Strahan JH (1984) Quinine by intravenous drip in the treatment of acute falciparum malaria. Trans R Soc Trop Med Hyg 41: 669–676
Swerdlow CD, Yu Jo, Jacobson E, Mann S, Winkle RA, Griffin JC, Ross DL, Mason JW (1983) Safety and efficacy of intravenous quinidine. Am J Med 75: 36–42
Taggart JV, Earle DP, Berliner RW, Zubrod CG, Welch WJ, Bowman-Wise N, Schroeder EF, London IM, Shannon JA (1948) Studies on the chemotherapy of the human malarias. III. The physiological disposition and antimalarial activity of the cinchona alkaloids. J Clin Invest 27: 80–86
Veenendaal JR, Edstein MD, Rieckman KH (1987) Pharmacokinetics of chlorproguanil in man after a single dose of Lapudrine. Chemotherapy (in press)
Walker D, Dawodu AH, Adeyokunnu AA, Salako LA, Alvan G (1983a) Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol 16: 701–705
Walker O, Birkett DJ, Alvan G, Gustafsson LL, Sjöqvist F (1983b) Characterisation of chloroquine plasma protein binding in man. Br J Clin Pharmacol 15: 375–377
Ward SA, Mihaly GW, Edwards G, et al. (1985) Pharmacokinetics of primaquine in man II comparison of acute vs chronic dosage in Thai subjects. Br J Clin Pharmacol 19: 751–755
Watkins WM, Chulay JD, Sixsmith DG, Spencer HC, Howells RE (1987) A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil. J Pharm Pharmacol 39: 261–265
Watkins WM, Sixsmith DG, Spencer HC, Boriga DA, Kariuki DM, Kipingor T, Koech DK (1984) Effectiveness of amodiaquine as treatment for chloroquine-resistantPlasmodium falciparum in Kenya. Lancet 1: 357–359
Wattanagoon Y, Taylor RB, Moody RRA, Silamut K, Looareesuwan S, White NJ (1987) Single dose pharmacokinetics of proguanil and its metabolites in healthy adult volunteers. Br J Clin Pharmacol (in press)
Weidekamm E, Plozza-Nottebrock H, Forgo I, Dubach DC (1982) Plasma concentrations of pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerised curve fitting. Bull WHO 60: 115–122
White NJ, Looareesuwan S, Warrell DA, Chongsuphajaisiddhi T, Bunnag D, Harinasuta T (1981) Quinidine in falciparum malaria. Lancet 2: 1069–1071
White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Bunnag D, Harinsasuta T (1982) Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 73: 564–572
White NJ, Chanthavanich P, Krishna S, Bunch C, Silamut K (1983a) Quinine disposition kinetics. Br J Clin Pharmacol 16: 399–404
White NJ, Looareesuwan S, Silamut K (1983b) Red cell quinine concentrations in falciparum malaria. Am J Trop Med Hyg 32: 456–460
White NJ, Looareesuwan S, Warrell DA (1983c) Quinine and quinidine: A comparison of EKG effects during the treatment of malaria. J Cardiovasc Pharmacol 5: 173–175
White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S, Williamson DH, Turner RC (1983d) Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 309: 61–66
White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Chanthavanich P, Bunnag D, Harinsasuta T (1983e) Quinine loading dose in cerebral malaria. Am J Trop Med Hyg 32: 1–5
White NJ (1985a) Clinical pharmacokinetics of the antimalarial drugs. Clin Pharmacokinet 10: 187–215
White NJ (1985b) Loading dose in antimalarial prophylaxis. Trans R Soc Trop Med Hyg 79: 742
White NJ (1987a) The pharmacokinetics of quinine and quinidine in malaria. Acta Leidensia 55: 65–76
White NJ, Miller KD, Marsh K, Berry CD, Turner RC, Williamson DH, Brown J (1987b) Hypoglycaemia in African children with severe malaria. Lancet 1: 707–711
White NJ, Watt G, Bergqvist Y, Njelesani E (1987c) Parenteral chloroquine in the treatment of falciparum malaria. J Infect Dis 155: 192–201
White NJ, Looareesuwan S, Edwards G, Phillips RE, Karbwang J, Nicholl DD, Bunch C, Warrell DA (1987d) Pharmacokinetics of intravenous amodiaquine. Br J Clin Pharmacol 23: 127–135
White NJ (1987d) Combination treatment for falciparum prophylaxis. Lancet 1: 680–681
Winstanley P, Edwards G, Drme M, Breckenridge A (1987) The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol 23: 1–7
Wiselogle FW (1946) A survey of antimalarial drugs 1941–1945. JW Edwards, Ann Arbor, Michigan, pp 1–536
World Health Organization (1981) Chemotherapy of malaria ed. LJ Bruce-Chwatt (ed), 2nd edn, Geneva
World Health Organization (1984) Advances in malaria chemotherapy. Tech Rep Series 711
World Health Organization (1986) Severe and complicated malaria. Trans R Soc Trop Med Hyg 80 [Suppl]: 1–50
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
White, N.J. Drug treatment and prevention of malaria. Eur J Clin Pharmacol 34, 1–14 (1988). https://doi.org/10.1007/BF01061409
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01061409